Cargando…
Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcome
Patients with subarachnoid hemorrhage (SAH) who are using antiplatelet drugs prior to their hemorrhage, often receive platelet transfusions to reverse antiplatelet effects prior to life-saving surgical interventions. However, little is known about the effect of platelet transfusion on patient outcom...
Autores principales: | Post, R., Tjerkstra, M. A., Middeldorp, S., Van den Berg, R., Roos, Y. B. W. E. M., Coert, B. A., Verbaan, D., Vandertop, W. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972790/ https://www.ncbi.nlm.nih.gov/pubmed/31964972 http://dx.doi.org/10.1038/s41598-020-57683-7 |
Ejemplares similares
-
Aneurysm treatment within 6 h versus 6–24 h after rupture in patients with subarachnoid hemorrhage
por: Vergouwen, Mervyn DI, et al.
Publicado: (2023) -
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome
por: Sebök, Martina, et al.
Publicado: (2021) -
Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review
por: Tjerkstra, Maud A., et al.
Publicado: (2023) -
Clinical and Laboratory Characteristics for the Diagnosis of Bacterial Ventriculitis After Aneurysmal Subarachnoid Hemorrhage
por: Hoogmoed, J., et al.
Publicado: (2016) -
Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
por: Germans, Menno R, et al.
Publicado: (2013)